Search
Nine students will don caps and gowns to celebrate their academic achievements and receive their PhDs from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK).
Hear from GSK Alumni Lindsey, Prashant, and Theresa, as they share more about their experience and where their careers have taken them.
Cancer biologist Andrea Ventura is the incumbent of a Geoffrey Beene Junior Faculty Chair at the Sloan Kettering Institute, he devotes his research to the nascent field of microRNA expression, seeking to understand how these small RNAs act on genes to promote or suppress cancer.
Called NEXT, the factor plays an important role in handing over RNA to the exosome for destruction.
The discovery links metabolism to the way cancer stem cells form tumors.
Researchers have discovered how a high level of the protein PSMA in cells helps fuel prostate cancer.
A lesser-known immune cell is suddenly getting more attention in the field of cancer immunology.
Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.
Maria Jasin, a member of the Sloan Kettering Institute’s Developmental Biology Program, discusses her research.
This year, the GSK student-run Experimental Therapeutics Symposium highlighted MSK’s expertise in successfully moving novel therapies from bench to bedside.